Saline Solution Injection Recalled Nationwide Due to Sterility and Leakage
Fresenius Medical Care is recalling 0.9% Sodium Chloride Injection distributed nationwide due to lack of assurance of sterility and potential leakage. Multiple lot numbers with expiration dates ranging from May 2023 to August 2023 are affected.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of an injectable pharmaceutical product with lack of sterility assurance and potential leakage. While the hazard poses significant risk of infection for injectable solutions, no illnesses or injuries have been reported. Per the severity rubric, this qualifies as a high-risk situation where injury has not yet been reported.
Plain-English summary
Fresenius Medical Care Holdings, Inc. is recalling 0.9% Sodium Chloride Injection, USP, a sterile injectable saline solution distributed nationwide. The product is supplied in 1-liter bags, packaged in cases of 12 bags each. The recall affects approximately 16,006 cases.
The recall is being issued due to lack of assurance of sterility and potential leakage of the product. The affected lot numbers include 22EU05043 (expiration 5/21/2023), 22HU05018 (6/9/2023), 22HU05019 (6/10/2023), 22HU05025 (6/12/2023), 22HU05026 (6/12/2023), 22HU05049 (6/22/2023), 22HU05053 (6/24/2023), 22HU05054 (6/25/2023), 22HU05055 (6/25/2023), 22HU06027 (6/11/2023), 22HU06049 (6/23/2023), 22HU06055 (6/24/2023), 22HU06056 (6/25/2023), 22JU05008 (7/4/2023), 22KU06036 (8/19/2023), and 22JU06023 (7/8/2023).
The product was distributed nationwide in the USA. Healthcare facilities and providers who have received this product should verify they do not possess the affected lot numbers and should not use the product if the lot number matches one of the recalled batches.
The recalled product
- Product
- SODIUM CHLORIDE (SODIUM CHLORIDE)
- Brand
- SODIUM CHLORIDE
- Manufacturer
- Fresenius Medical Care Holdings, Inc.
- Category
- Drug — Injectable / IV Solution
- Hazard
- lack-of-sterility
- leakage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot # 22EU05043
- EXP 5/21/2023
- 22HU05018
- EXP 6/9/2023
- 22HU05019
- EXP 6/10/2023
- 22HU05025
- 22HU05026
- EXP 6/12/2023
- 22HU05049
- EXP 6/22/2023
- 22HU05053
- EXP 6/24/2023
- 22HU05054
- 22HU05055
- EXP 6/25/2023
- 22HU06027
- EXP 6/11/2023
- 22HU06049
- EXP 6/23/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · SODIUM CHLORIDE
- SevereFresenius Sodium Chloride Injection Recall: Lack of Sterility Assurance
FDA (Drugs) · 2025-07-02
- SevereSodium Chloride Injection Recalled for Sterility Assurance Defect
FDA (Drugs) · 2025-07-02
- ModerateSodium Chloride Irrigation Solution Recalled for Particulate Matter
FDA (Drugs) · 2025-04-16
- SevereFDA Class I Recall: B. Braun Sodium Chloride Injection for Particulate Matter
FDA (Drugs) · 2024-08-28
- ModerateIntravenous Sodium Chloride Injection Recalled for Incomplete Labeling and Warnings
FDA (Drugs) · 2023-08-16
Same category
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22